Valeant buys 'female Viagra' maker for $1 bn
Canada's Valeant Pharmaceuticals is paying $1 billion to buy Sprout Pharmaceuticals, which just won US government approval to sell the first "female Viagra" drug, the firms announced on Thursday.
Aug 20, 2015, 19:51 PM IST
Endo to buy Par Pharmaceutical for $8.05 billion
Endo International will buy Par Pharmaceutical Holdings in a $8.05 billion deal that will strengthen Endo`s generic drugs business, the companies said Monday.
May 18, 2015, 20:48 PM IST